DAX22.668 +1,5%ESt505.356 +0,9%Top 10 Crypto11,67 +1,5%Dow41.448 ±0,0%Nas17.713 +1,6%Bitcoin75.197 -0,9%Euro1,0908 -0,1%Öl70,83 +1,3%Gold2.934 +0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Tesla A1CX3T NVIDIA 918422 PUMA 696960 HENSOLDT HAG000 RENK RENK73 NEL ASA A0B733 Siemens Energy ENER6Y Volkswagen (VW) vz. 766403 Eutelsat Communications A0HGPT Amazon 906866 thyssenkrupp 750000 Microsoft 870747 Apple 865985 Deutsche Telekom 555750
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht fest in den Feierabend -- Rheinmetall erhöht nach Gewinnsprung Dividende -- PUMA erwartet Gewinnrückgang -- Siemens Energy, Porsche, NEL, Plug Power, Intel, Strategy, Tesla im Fokus
Top News
BÖRSE AKTUELL: DAX hält Erholungskurs aufrecht BÖRSE AKTUELL: DAX hält Erholungskurs aufrecht
So bewegen sich Bitcoin & Co. heute So bewegen sich Bitcoin & Co. heute
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
+++ Finanz-Event für Privatanleger & Trader: 15 Expertenvorträge beim Börsentag Köln am 22. März 2025 - jetzt kostenfrei anmelden! +++

OsteoStrong Hosts Public Webinar on GLP-1's Impact on Bone Health and Newly Published Osteoporosis Research

12.03.25 13:38 Uhr

NASHVILLE, Tenn., March 12, 2025 /PRNewswire/ -- OsteoStrong, the global leader in osteogenic loading technology, is hosting a live webinar featuring CEO Kyle Zagrodzky and biomedical engineer Dr. John Jaquish to discuss newly published research on osteoporosis and the side effects of GLP-1 medications, like Ozempic, on bone health.

The study recently published in The Journal of Clinical Endocrinology & Metabolism (JCEM), demonstrates that OsteoStrong's low impact, high intensity osteogenic loading system significantly improves bone mineral density in postmenopausal women with osteoporosis. As the use of GLP-1 medications rises, so do concerns about their potential link to increased bone loss and fracture risk. This webinar will provide key insights into the latest scientific findings and their implications for long-term musculoskeletal health.

Attendees will gain insights into:

  • The newly published study and how osteogenic loading improves bone density in postmenopausal women
  • The potential side effects of GLP-1 medications on bone health
  • How OsteoStrong's technology is providing a drug-free approach to strengthening bones and improving musculoskeletal health

Event Details:

  • Date: Thursday, March 13, 2025
  • Time: 4:00 p.m. PST, 6:00 p.m. CST, 7:00 p.m. EST
  • Where: Virtual, open to the public
  • Registration Link: CLICK HERE

This webinar is an opportunity to hear directly from experts about the latest advancements in bone health and how to protect against osteoporosis and medication-related risks. Registration is open to all who want to learn more about strengthening their bones and overall musculoskeletal health.

About OsteoStrong®
OsteoStrong® is a science-backed, technology-driven system designed to improve bone density, strength, and overall skeletal health. With locations worldwide, OsteoStrong® helps people of all ages build stronger bones in a safe, efficient, and drug-free manner.

For more information about the study or OsteoStrong®, visit www.osteostrong.me.

Media Contact
Interdependence Public Relations
949-259-6377 x 225
391616@email4pr.com 

Cision View original content:https://www.prnewswire.com/news-releases/osteostrong-hosts-public-webinar-on-glp-1s-impact-on-bone-health-and-newly-published-osteoporosis-research-302399292.html

SOURCE OsteoStrong